INSIGHTS ON QUALITY ASSURANCE

• A System For Annex 1 Data, Reporting, And Interpretation Requirements

  Watch this tech expo video to discover how multi-dimensional sensor placement and integrated data dashboards optimize cleanroom environmental monitoring for Annex 1 compliance.

• AI In Quality: Practical Applications, Regulatory Perspectives, And Preparing QA Teams

  Integrating AI into regulated workflows requires robust risk-based validation, human oversight, and data integrity to ensure compliance with evolving global regulatory frameworks.

• The Transformational Impact Of A Digital Backbone

  Relying on fragmented data becomes problematic when teams need to dissect cell line performance data and that data is not in a digital backbone.

• Scaling Down For Success: Optimizing Single-Use Virus Filtration For Small-Scale Bioprocessing

  Automation can bring greater consistency, product recovery, data capture, and operational efficiency to small-scale viral filtration once processes are sufficiently defined, helping gene therapy developers transition beyond highly manual workflows.

• Regulatory Compliance And Audits For Parenteral Manufacturing Precision

  6/30/2025

  CMOs play a critical role in regulatory compliance for parenteral manufacturing, using audits, quality systems, and proactive strategies to ensure product safety and patient well-being.

• Maintain Control Of Pharmaceutical Water Systems

  4/10/2026

  Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

• Denaturing SEC-MS Analysis Of High Molecular Weight Impurities

  3/18/2026

  Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.

• EU And PIC/S Annex 1: CCS Shortfalls After 2 Years Of Implementation

  4/16/2026

  Explore how to elevate Contamination Control Strategies from static documents to inspection-ready, lifecycle tools, as well as practical approaches to Annex 1 compliance and risk-based CCS development.

• Optimizing Antibody Variant Capture: Strategies To Combat Aggregation, Impurities, And Low Yields

  2/26/2026

  Explore how process conditions affect bispecific antibody stability and impurity formation, as well as practical strategies to minimize aggregation and remove product‑related variants.